Publication | Open Access
Role of Cytokines and Vaccines in Break through COVID 19 Infections
29
Citations
0
References
2021
Year
ImmunologyImmune SystemCovid-19Influenza VaccinesVaccine TargetVaccine SurveillanceCovid-19 VaccineVaccinologyVaccine SafetyVaccine DevelopmentCovid-19 PandemicHumoral ImmunityCovid 19VaccinationPrecision VaccinologyVaccine EfficacyMedicineVaccine ResearchViral ImmunityGoogle Scholar
Background: Despite efforts to develop a COVID-19 vaccine, it has failed to provide long-term immunity and protection against COVID-19 and the newly worrying SARS-CoV-2 coronavirus strains. Understanding cytokines, which are key in generating unique immune responses from pathogenic organisms, is important for creating vaccines.
 Objective: In order to better understand cytokines and how the current COVID-19 vaccinations can assist reactivate latent cytokines, the scientific community and the general public must be educated.
 Materials and Methods: Medical and scientific indexing sources like PubMed and Google Scholar were used to search for relevant medical and scientific publications.
 Results: After vaccination, cytokines in the immune system can be activated, which can help signal chemicals that can increase the immune system's ability to fight against new and break-through COVID 19 infections.
 Conclusion: It has been discovered that both the Pfizer-BioNTech and the Moderna vaccines are safe and effective in preventing break through COVID-19 infections, regardless of whether the patient experiences symptoms or not. It is an adenovirus, not an mRNA, that Johnson & Johnson's vaccine is made of.